Pekka Hannonen

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo‐Repo et al. · The Lancet · 1999 · 868 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Delay to institution of therapy and induction of remission using single‐drug or combination–disease‐modifying antirheumatic drug therapy in early rheumatoid arthritis

Timo Möttönen, Pekka Hannonen, Markku Korpela et al. · Arthritis & Rheumatism · 2002 · 419 citations

Life Sciences, Immunology, Pharmacotherapy +15

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: Five‐year experience from the FIN‐RACo study

Markku Korpela, Leena Laasonen, Pekka Hannonen et al. · Arthritis & Rheumatism · 2004 · 277 citations

Medicine, Internal Medicine, Pharmacotherapy +11

A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis

Arja H�kkinen, Tuulikki Sokka, A Kotaniemi et al. · Arthritis & Rheumatism · 2001 · 245 citations

Medicine, Clinical Sciences, Rehabilitation Medicine +17

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial

Kari Puolakka, Hannu Kautiainen, Timo Möttönen et al. · Arthritis & Rheumatism · 2005 · 231 citations

Medicine, Chronic Disease Control, Autoimmunity +14